Literature DB >> 21732730

Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy.

Aleksandra Araszkiewicz1, Anita Rogowicz-Frontczak, Dorota Zozulinska-Ziolkiewicz, Stanislaw Pilacinski, Andrzej Wykretowicz, Bogna Wierusz-Wysocka.   

Abstract

PURPOSE: The aim of the study was to assess the relationships between diabetic retinopathy, subclinical atherosclerosis and wave reflection in type 1 diabetic patients.
METHODS: The investigation involved 87 type 1 diabetic patients aged 34 years (interquartile range [IQR]: 29-43), with a disease duration of 10 years (IQR: 9-14). Of these 39 (45%) had diabetic retinopathy. Carotid intima-media thickness (CIMT) was measured using high resolution ultrasonography. Wave reflection and central hemodynamics [central (CAI(x)) and peripheral augmentation index (PAI(x))] were determined with the use of tonometry.
RESULTS: Patients with retinopathy compared to those without had increased CIMT (530 vs 480 μm, p = 0.017) and wave reflection (CAI(x) [118.90 vs 110.96 %, p = 0.03] and PAI(x) [64.95 vs 57.44 %, p = 0.029]). In logistic regression analysis, patient's age, duration of diabetes, systolic and diastolic blood pressure, postprandial glycemia, HbA1c value, CIMT (p = 0.017), CAI(x) (p = 0.03) and PAI(x) (p = 0.016) were associated with the presence of diabetic retinopathy. However, in the multivariate model, CIMT and CAI(x) did not remain predictors of retinopathy.
CONCLUSIONS: We have shown that the presence of retinopathy in type 1 diabetic patients is associated with subclinical atherosclerosis and wave reflection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732730     DOI: 10.3109/00365513.2011.593268

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes.

Authors:  Marc Carbonell; Esmeralda Castelblanco; Xavier Valldeperas; Àngels Betriu; Alícia Traveset; Minerva Granado-Casas; Marta Hernández; Federico Vázquez; Mariona Martín; Esther Rubinat; Albert Lecube; Josep Franch-Nadal; Elvira Fernández; Manel Puig-Domingo; Angelo Avogaro; Núria Alonso; Dídac Mauricio
Journal:  Cardiovasc Diabetol       Date:  2018-05-04       Impact factor: 9.951

2.  Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.

Authors:  Hai Xie; Chaoyang Zhang; Dandan Liu; Qian Yang; Lei Tang; Tianqin Wang; Haibin Tian; Lixia Lu; Jing-Ying Xu; Furong Gao; Juan Wang; Caixia Jin; Weiye Li; Guoxu Xu; Guo-Tong Xu; Jingfa Zhang
Journal:  Diabetologia       Date:  2020-10-26       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.